Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population
- 19 January 2021
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 23 (7) , 1463-1473
Abstract
Objectives Due to a steadily growing use of stereotactic radiotherapy (SRT) for treatment of brain metastases (BMs), the in-field failure after an initial stereotaxy is an increasingly frequent problem. Repeat stereotactic radiotherapy (re-SRT) shows encouraging results in terms of local control. However, the evidence on prognostic factors limiting the overall survival (OS) of re-treated patients is scarce. Here, we sought to analyze the patients’ and treatment characteristics influencing the survival outcomes after re-SRT. Methods Data of all patients with local failure of initial SRT treated from 2012 to 2019 were retrospectively reviewed and cases treated with salvage SRT were analyzed. We analyzed the impact of patients’ and treatment characteristics on overall survival after re-SRT by Kaplan–Meier method and Cox regression models. Local and distant brain control, cause of death, and radionecrosis rate were also assessed. Results Forty-seven patients with 55 BMs treated with re-SRT were evaluated. Median OS after re-SRT was 9.2 months and the overall local control was 83.6%. Nine BMs (16.4%) presented local relapse (LR), 12 (21.8%) radionecrosis, while 21 patients (44.7%) developed new BMs. Only absence of extracranial metastases at BMs diagnosis (HR 0.42, CI 95%; 0.18–0.97), extracranial disease progression (HR 2.39, CI 95%; 1.06–5.38) and distant brain failure (HR 3.94, CI 95%; 1.68–9.24) after re-SRT were significantly associated with patients’ survival. Extracranial progression following re-SRT was an independent prognosticator of worse OS. Conclusion Re-SRT after LR presented excellent local control with acceptable RN rate and improved patients’ survival, limited mainly by extracranial and distant brain progression.Keywords
Funding Information
- SEOR (This study received grant from the Spanish Society of Radiation Oncology (SEOR) and CRIS Foundation 2018)
This publication has 31 references indexed in Scilit:
- Repeat Stereotactic Radiosurgery for Locally Recurrent Brain MetastasesWorld Neurosurgery, 2017
- Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgeryJournal of Neurosurgery, 2017
- Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based studyNeuro-Oncology, 2017
- Tumor Bed Radiosurgery Following Resection and Prior Stereotactic Radiosurgery for Locally Persistent Brain MetastasisFrontiers in Oncology, 2015
- Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experienceLa radiologia medica, 2014
- Salvage Radiosurgery for Brain Metastases: Prognostic Factors to Consider in Patient SelectionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Reirradiation of brain metastases with radiosurgeryRadiotherapy and Oncology, 2012
- Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged SurvivalWorld Neurosurgery, 2011
- Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosisRadiation Oncology, 2011
- Radiosurgical Salvage Therapy for Patients Presenting with Recurrence of Metastatic Disease to the BrainNeurosurgery, 2000